|
Status |
Public on Sep 18, 2017 |
Title |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Methylation profiling by high throughput sequencing Other
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
|
Submission date |
Mar 16, 2016 |
Last update date |
May 15, 2019 |
Contact name |
James Bradner |
E-mail(s) |
bradner_computation@dfci.harvard.edu
|
Organization name |
Dana-Farber Cancer Institute
|
Department |
Medical Oncology
|
Lab |
Bradner Lab
|
Street address |
450 Brookline
|
City |
Boston |
State/province |
MA |
ZIP/Postal code |
02215 |
Country |
USA |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (58)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE79253 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [RNA-seq] |
GSE79271 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] |
GSE79288 |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [ChIP-seq] |
|
Relations |
BioProject |
PRJNA315412 |